Artisan Partners
RYTM icon

Artisan Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Artisan Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.4M Sell
354,816
-35,853
-9% -$3.24M 0.06% 187
2026
Q1 		$34M Buy
390,669
+127,078
+48% +$12.4M 0.05% 239
2025
Q4 		$28.2M Buy
263,591
+26,750
+11% +$2.84M 0.04% 276
2025
Q3 		$23.9M Buy
236,841
+62,362
+36% +$5.79M 0.03% 273
2025
Q2 		$11M Buy
+174,479
New +$10.7M 0.02% 310
2024
Q3 		– Sell
-271,267
Closed -$11.1M – 366
2024
Q2 		$11.1M Sell
271,267
-154
-0.1% -$6.15K 0.02% 302
2024
Q1 		$11.8M Hold
271,421
– – 0.02% 295
2023
Q4 		$12.5M Buy
+271,421
New +$8.56M 0.02% 284

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners's RYTM Position: Q2 2026 in Review

Artisan Partners reduced its Rhythm Pharmaceuticals (RYTM) stake by 9.2% in Q2 2026, selling an estimated $3.24M and leaving 354,816 shares worth $39.4M. The position accounts for 0.06% of the portfolio, ranked #187.

Artisan Partners first reported a position in RYTM in Q4 2023 and has held it in 8 quarters since. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Artisan Partners held 354,816 shares of Rhythm Pharmaceuticals worth $39.4M as of Q2 2026.
  • Artisan Partners sold 35,853 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $3.24M.
  • Rhythm Pharmaceuticals made up 0.06% of Artisan Partners's portfolio in Q2 2026, its #187 holding.
  • Artisan Partners first reported a position in Rhythm Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.